| 1 |
2024 |
Naranjan S. Dhalla, Karina O. Mota, Vijayan Elimban, Anureet K. Shah, Carla M. L. de Vasconcelos, Sukhwinder K. Bhullar. Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure, Cells. 2024; 13: 856.
https://doi.org/10.3390/cells13100856 |
| 2 |
2022 |
Sukhwinder K. Bhullar, Naranjan S. Dhalla. Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy, Cells. 2022; 11: 3336.
https://doi.org/10.3390/cells11213336 |
| 3 |
2022 |
Chang-E Yang, Yan-Ni Wang, Meng-Ru Hua, Hua Miao, Ying-Yong Zhao, Gang Cao. Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis, Ageing Research Reviews. 2022; 79: 101662101662.
https://doi.org/10.1016/j.arr.2022.101662 |
| 4 |
2022 |
Naranjan S. Dhalla, Anureet K. Shah, Adriana Adameova, Monika Bartekova. Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury, Biomedicines. 2022; 10: 1473.
https://doi.org/10.3390/biomedicines10071473 |
| 5 |
2023 |
Li-Li Ren, Xiao-Jun Li, Ting-Ting Duan, Zheng-Hai Li, Jun-Zheng Yang, Ya-Mei Zhang, Liang Zou, Hua Miao, Ying-Yong Zhao. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities, Chemico-Biological Interactions. 2023; 369: 110289110289.
https://doi.org/10.1016/j.cbi.2022.110289 |
| 6 |
2024 |
Sukhwinder K. Bhullar, Naranjan S. Dhalla. Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure, Canadian Journal of Physiology and Pharmacology. 2024; 102: 86.
https://doi.org/10.1139/cjpp-2023-0226 |
| 7 |
2022 |
Cody Rutledge, Angela Enriquez, Kevin Redding, Mabel Lopez, Steven Mullett, Stacy Wendell, Michael Jurczak, Eric Goetzman, Brett A. Kaufman. 2022;
https://doi.org/10.1101/2022.08.23.504997 |
| 8 |
2024 |
Jasneet Tiwana, Anureet Shah, Naranjan Dhalla. The involvement of reactive oxygen species in causing chronic cardiovascular and neurodegenerative diseases and some cancers, Scripta Medica. 2024; 55: 199.
https://doi.org/10.5937/scriptamed55-48730 |
| 9 |
2023 |
Cody Rutledge, Angela Enriquez, Kevin Redding, Mabel Lopez, Steven Mullett, Stacy L. Gelhaus, Michael Jurczak, Eric Goetzman, Brett A. Kaufman. Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation, Cardiovascular Drugs and Therapy. 2023;
https://doi.org/10.1007/s10557-023-07482-9 |
| 10 |
2023 |
Muhammad Abubakar, Ayesha Saleem, Mohsin Hajjaj, Haseeb Faiz, Aastha Pragya, Rosheen Jamil, Siffat Saima Salim, Ibrahim Khaleel Lateef, Deepak Singla, Rajasekar Ramar, Ivan Damara, Laraib Shahid. Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction: A comprehensive literature review, Heart Failure Reviews. 2023;
https://doi.org/10.1007/s10741-023-10369-4 |
| 11 |
2022 |
Sukhwinder Bhullar, Anureet Shah, Naranjan Dhalla. Mechanisms for the development of heart failure and improvement of cardiac function by angiotensin-converting enzyme inhibitors, Scripta Medica. 2022; 53: 51.
https://doi.org/10.5937/scriptamed53-36256 |
| 12 |
2022 |
Yan-Ni Wang, Hong-Jiao Liu, Li-Li Ren, Ping Suo, Liang Zou, Ya-Mei Zhang, Xiao-Yong Yu, Ying-Yong Zhao. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway, Frontiers in Pharmacology. 2022; 13: 964370.
https://doi.org/10.3389/fphar.2022.964370 |
| 13 |
2024 |
Andrés G. Restrepo Guerrero, Valeria R. Martinez, Jorge O. Velez Rueda, Enrique L. Portiansky, Verónica De Giusti, Evelina G. Ferrer, Patricia A.M Williams. Complexation of the Antihypertensive Drug Olmesartan with Zn: In Vivo Antihypertensive and Cardiac Effects, Biological Trace Element Research. 2024; 202: 246.
https://doi.org/10.1007/s12011-023-03670-8 |
| 14 |
2023 |
Mohamad Nusier, Vijayan Elimban, Jaykishan Prasad, Anureet Shah, Naranjan Dhalla. Regulatory role of some protein kinases in signal transduction pathways in heart health and disease, Scripta Medica. 2023; 54: 181.
https://doi.org/10.5937/scriptamed54-42460 |
| 15 |
2024 |
Hua Miao, Yan-ni Wang, Wei Su, Liang Zou, Shou-gang Zhuang, Xiao-yong Yu, Fei Liu, Ying-yong Zhao. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway, Acta Pharmacologica Sinica. 2024; 45: 137.
https://doi.org/10.1038/s41401-023-01148-w |
